STOCK TITAN

[Form 4] Progyny, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Progyny, Inc. (PGNY) insider Allison Swartz, EVP and General Counsel, reported two transactions on 09/04/2025. 339 shares were withheld to satisfy taxes on vested restricted stock units at a per-share value of $23.54, and 599 shares were sold at $23.53 under a Rule 10b5-1 trading plan entered May 13, 2025. The filings show 78,006 shares beneficially owned after the withholding event and 77,407 shares after the sale, reflecting a net reduction in direct holdings. The Form 4 was signed by an attorney-in-fact on 09/05/2025.

Progyny, Inc. (PGNY): l'insider Allison Swartz, vicepresidente esecutiva e consigliera generale, ha registrato due operazioni il 04/09/2025. Sono state 339 azioni trattenute per coprire le imposte su restricted stock unit maturate, al valore unitario di $23,54, e 599 azioni sono state vendute a $23,53 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 attivato il 13/05/2025. I documenti indicano 78.006 azioni possedute in via beneficiaria dopo la trattenuta e 77.407 azioni dopo la vendita, a fronte di una riduzione netta della partecipazione diretta. Il Modulo 4 è stato firmato da un procuratore il 05/09/2025.

Progyny, Inc. (PGNY): la insider Allison Swartz, vicepresidenta ejecutiva y consejera general, comunicó dos operaciones el 04/09/2025. Se retuvieron 339 acciones para cubrir impuestos sobre unidades restringidas (RSU) consolidadas, a un valor por acción de $23,54, y se vendieron 599 acciones a $23,53 bajo un plan de trading conforme a la Regla 10b5-1 suscrito el 13/05/2025. Las presentaciones muestran 78.006 acciones en propiedad beneficiaria tras la retención y 77.407 acciones tras la venta, reflejando una reducción neta de la tenencia directa. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

Progyny, Inc. (PGNY) 내부자 Allison Swartz(수석부사장 겸 법무총괄)가 2025-09-04에 두 건의 거래를 신고했습니다. 339주는 기성 제한주(RSU)의 세금을 충당하기 위해 원천징수되었고 주당 가치는 $23.54였습니다. 또한 599주는 2025-05-13에 체결된 Rule 10b5-1 거래계획에 따라 주당 $23.53에 매도되었습니다. 제출서류에는 원천징수 이후 78,006주의 실소유가, 매도 후에는 77,407주가 기재되어 있어 직접 보유량이 순감소했음을 나타냅니다. Form 4는 2025-09-05에 대리인이 서명했습니다.

Progyny, Inc. (PGNY) : l'initié Allison Swartz, vice-présidente exécutive et conseillère générale, a déclaré deux opérations le 04/09/2025. 339 actions ont été retenues pour couvrir les impôts sur des unités d'actions restreintes devenues acquises, au prix unitaire de 23,54 $, et 599 actions ont été vendues à 23,53 $ dans le cadre d'un plan de négociation Rule 10b5-1 conclu le 13/05/2025. Les documents indiquent 78 006 actions détenues bénéficiairement après la retenue et 77 407 actions après la vente, reflétant une diminution nette de la participation directe. Le formulaire 4 a été signé par un mandataire le 05/09/2025.

Progyny, Inc. (PGNY): Insider Allison Swartz, Executive Vice President und General Counsel, meldete zwei Transaktionen am 04.09.2025. 339 Aktien wurden einbehalten, um Steuern auf verfallene Restricted Stock Units zu begleichen, zum Preis von $23,54 je Aktie, und 599 Aktien wurden zum Preis von $23,53 im Rahmen eines am 13.05.2025 geschlossenen Rule-10b5-1-Handelsplans verkauft. Die Einreichungen weisen nach der Einbehaltung 78.006 Aktien und nach dem Verkauf 77.407 Aktien als wirtschaftlichen Besitz aus, was auf eine Nettoreduktion der direkten Beteiligung hinweist. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Transaction executed under a Rule 10b5-1 plan, indicating pre-established, compliant trading procedures
  • Tax withholding on vested RSUs was handled by share withholding rather than cash, a routine administrative action
Negative
  • Insider sold 599 shares, reducing direct beneficial ownership from 78,006 to 77,407 shares
  • Overall holdings declined following the combined withholding and sale transactions

Insights

TL;DR: Routine insider tax withholding and plan-based sale, showing governance compliance without material ownership shift.

The Form 4 discloses standard tax-withholding on vested RSUs and a small block sale executed under a pre-established Rule 10b5-1 plan. Both actions follow common insider compensation and liquidity practices and signal procedural compliance rather than opportunistic trading. The post-transaction beneficial ownership decline from 78,006 to 77,407 shares is small relative to typical public-company float and does not indicate a governance change or management turnover.

TL;DR: Minor share disposition; sales were executed under a 10b5-1 plan and for tax withholding on RSU vesting.

The reported sale of 599 shares at $23.53 and the withholding of 339 shares at $23.54 are modest in size and were conducted under documented mechanisms: tax withholding for RSUs and a 10b5-1 trading plan dated May 13, 2025. These details reduce the likelihood the trades were based on material nonpublic information. The transactions slightly reduced direct holdings but represent routine insider activity rather than a signal of company performance shifts.

Progyny, Inc. (PGNY): l'insider Allison Swartz, vicepresidente esecutiva e consigliera generale, ha registrato due operazioni il 04/09/2025. Sono state 339 azioni trattenute per coprire le imposte su restricted stock unit maturate, al valore unitario di $23,54, e 599 azioni sono state vendute a $23,53 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 attivato il 13/05/2025. I documenti indicano 78.006 azioni possedute in via beneficiaria dopo la trattenuta e 77.407 azioni dopo la vendita, a fronte di una riduzione netta della partecipazione diretta. Il Modulo 4 è stato firmato da un procuratore il 05/09/2025.

Progyny, Inc. (PGNY): la insider Allison Swartz, vicepresidenta ejecutiva y consejera general, comunicó dos operaciones el 04/09/2025. Se retuvieron 339 acciones para cubrir impuestos sobre unidades restringidas (RSU) consolidadas, a un valor por acción de $23,54, y se vendieron 599 acciones a $23,53 bajo un plan de trading conforme a la Regla 10b5-1 suscrito el 13/05/2025. Las presentaciones muestran 78.006 acciones en propiedad beneficiaria tras la retención y 77.407 acciones tras la venta, reflejando una reducción neta de la tenencia directa. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

Progyny, Inc. (PGNY) 내부자 Allison Swartz(수석부사장 겸 법무총괄)가 2025-09-04에 두 건의 거래를 신고했습니다. 339주는 기성 제한주(RSU)의 세금을 충당하기 위해 원천징수되었고 주당 가치는 $23.54였습니다. 또한 599주는 2025-05-13에 체결된 Rule 10b5-1 거래계획에 따라 주당 $23.53에 매도되었습니다. 제출서류에는 원천징수 이후 78,006주의 실소유가, 매도 후에는 77,407주가 기재되어 있어 직접 보유량이 순감소했음을 나타냅니다. Form 4는 2025-09-05에 대리인이 서명했습니다.

Progyny, Inc. (PGNY) : l'initié Allison Swartz, vice-présidente exécutive et conseillère générale, a déclaré deux opérations le 04/09/2025. 339 actions ont été retenues pour couvrir les impôts sur des unités d'actions restreintes devenues acquises, au prix unitaire de 23,54 $, et 599 actions ont été vendues à 23,53 $ dans le cadre d'un plan de négociation Rule 10b5-1 conclu le 13/05/2025. Les documents indiquent 78 006 actions détenues bénéficiairement après la retenue et 77 407 actions après la vente, reflétant une diminution nette de la participation directe. Le formulaire 4 a été signé par un mandataire le 05/09/2025.

Progyny, Inc. (PGNY): Insider Allison Swartz, Executive Vice President und General Counsel, meldete zwei Transaktionen am 04.09.2025. 339 Aktien wurden einbehalten, um Steuern auf verfallene Restricted Stock Units zu begleichen, zum Preis von $23,54 je Aktie, und 599 Aktien wurden zum Preis von $23,53 im Rahmen eines am 13.05.2025 geschlossenen Rule-10b5-1-Handelsplans verkauft. Die Einreichungen weisen nach der Einbehaltung 78.006 Aktien und nach dem Verkauf 77.407 Aktien als wirtschaftlichen Besitz aus, was auf eine Nettoreduktion der direkten Beteiligung hinweist. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Swartz Allison

(Last) (First) (Middle)
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL

(Street)
NEW YORK NY 10018

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, GC
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/04/2025 F(1) 339 D $23.54 78,006 D
Common Stock 09/04/2025 S(2) 599 D $23.53 77,407 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
2. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on May 13, 2025.
Remarks:
/s/ Mark Livingston, Attorney-in-Fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Allison Swartz report on Form 4 for PGNY?

The Form 4 reports 339 shares withheld$23.54599 shares sold$23.53

Were the sales by the PGNY insider part of a trading plan?

Yes. The Form 4 states the sale of 599 shares was executed pursuant to a Rule 10b5-1 trading plan entered on May 13, 2025.

How did these transactions affect Allison Swartz's PGNY holdings?

Beneficial ownership was reported as 78,006 shares77,407 shares

What was the price per share for the reported transactions?

Withheld RSUs were recorded at $23.54$23.53

Who signed the Form 4 filing for the reporting person?

The form was signed by Mark Livingston, Attorney-in-Fact on 09/05/2025.
Progyny, Inc.

NASDAQ:PGNY

PGNY Rankings

PGNY Latest News

PGNY Latest SEC Filings

PGNY Stock Data

2.03B
79.45M
7.6%
104.43%
9.02%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
NEW YORK